DJIA 18,098.96 60.99 0.34%
NASDAQ 5,065.59 5.35 0.11%
S&P 500 2,112.84 3.92 0.19%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.62 0.02 (3.27%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.62 3.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.62
Previous Close $0.60
Daily Range $0.59 - $0.63
52-Week Range $0.54 - $2.43
Market Cap $43.1M
P/E Ratio -1.16
Dividend (Yield) $0.00 (0.0%)
Volume 3,302,380
Average Daily Volume 1,587,664
Current FY EPS -$0.51

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Dissecting StemCells Latest Capital Raise

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

Health Care Sector Update for 03/17/2015: STEM,ESPR,CNAT

Benzinga's Top #PreMarket Losers

StemCells' (STEM) CEO Martin McGlynn Discusses on Q4 2014 Results - Earnings Call Transcript

UPDATE: StemCells Posts Wider Q4 Net Loss

StemCells (STEM) Q4 2014 Results - Earnings Call Webcast

German Researchers Verify Positive, System-Wide Effect Of Pluristem's PLX Cell Therapy

Stem Cells Inc. Posts Letter to Shareholders

See More STEM News...

STEM's Top Competitors

STEM $0.62 (3.27%)
Current stock: STEM
AMGN $164.03 (1.02%)
Current stock: AMGN
GILD $103.55 (0.59%)
Current stock: GILD
BIIB $381.37 (-2.03%)
Current stock: BIIB